vitjВрач и информационные технологииMedical Doctor and Information Technologies1811-01932413-5208Pirogov National Medical and Surgical Center10.25881/18110193_2023_4_66vitj-136Research ArticleПРАКТИЧЕСКИЙ ОПЫТPRACTICE EXPERIENCEАпробация самостоятельного дистанционного мониторинга у беременных группы рискаApprobation of self-remote monitoring in high-risk pregnant womenДемкинаА. Е.DemkinaA. E.

 к.м.н.

г. Москва

PhD

Moscow

ademkina@bk.ruЛовцеваВ. А.LovtsevaV. A.

г. Череповец

Cherepovets

lovsevavika@yandex.ruДубровинаК. С.DubrovinaK. S.

 г. Череповец

Cherepovets

karishkaleto@mail.ruАслановаТ. М.AslanovaT. M.

г. Тюмень

Tyumen

Aslanovatarana@mail.ruРогожкинаЮ. А.RogozhkinaYu. A.

 г. Тюмень

Tyumen

yulia.ippolitova@gmail.comКарповаИ. А.KarpovaI. A.

г. Тюмень

Tyumen

karpovai.73@mail.ruЗингерманБ. В.ZingermanB. V.

г. Москва

Moscow

boriszing@gmail.comБородинР. А.BorodinR. A.

г. Москва

Moscow

roctbb@gmail.comИсаеваА. В.IsaevaA. V.

г. Екатеринбург

Ekaterinburg

av_isaeva_cgb20@mail.ruКоробейниковаА. Н.KorobeynikovaA. N.

 к.м.н.

г. Киров

 PhD

Kirov

anna_best2004@mail.ruГБУЗ «НПКЦ ДиТ ДЗМ"РоссияScientific and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Department of Health of the City of MoscowRussian FederationГБУЗ ВО «Череповецкий городской родильный дом»РоссияCherepovets City Maternity HospitalRussian FederationГАУЗ ТО «Городская поликлиника №17»РоссияTyumen city polyclinic №17Russian FederationГАУЗ ТО «Городская поликлиника №6»РоссияTyumen city polyclinic №6Russian FederationООО «АйПат»РоссияAipat LLCRussian FederationООО «ТелеПат»РоссияTelePat LLCRussian FederationФГБОУ ВО УГМУ Минздрава РоссииРоссияUral State Medical University of the Ministry of Health of RussiaRussian FederationКОГКБУЗ «Центр кардиологии и неврологии»РоссияCenter of Cardiology and NeurologyRussian Federation202301042025046678Copyright © Демкина А.Е., Ловцева В.А., Дубровина К.С., Асланова Т.М., Рогожкина Ю.А., Карпова И.А., Зингерман Б.В., Бородин Р.А., Исаева А.В., Коробейникова А.Н., 20252025Демкина А.Е., Ловцева В.А., Дубровина К.С., Асланова Т.М., Рогожкина Ю.А., Карпова И.А., Зингерман Б.В., Бородин Р.А., Исаева А.В., Коробейникова А.Н.Demkina A.E., Lovtseva V.A., Dubrovina K.S., Aslanova T.M., Rogozhkina Y.A., Karpova I.A., Zingerman B.V., Borodin R.A., Isaeva A.V., Korobeynikova A.N.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.vit-j.ru/jour/article/view/136Цель

Цель. Изучить возможности самостоятельного дистанционного мониторинга уровня артериального давления (АД) и частоты сердечных сокращений (ЧСС) у беременных группы риска.

 Материал и методы

 Материал и методы. В исследование по апробации самостоятельного мониторинга АД с использованием платформы MedSenger были включены женщины от 18 до 45 лет с артериальной гипертензией (хронической и гестационной), преэклампсией в анамнезе, высоким уровнем преэклампсии (выше 1:100), индексом массы тела >30 кг/м2. Пациентки при помощи домашнего тонометра измеряли ежедневно утром и вечером уровень АД и ЧСС и вносили данные личный кабинет приложения MedSenger в течение 1 месяца. Врач отслеживал параметры беременных, при отклонениях получал уведомления и принимал решение о дальнейшей тактике.

 Результаты

 Результаты. В исследование планировалось включить 59 пациенток, но от участия отказались 25 женщин (42,4%). Из 34 беременных (средний возраст 30,1±2,3 года) 5 не активировали программу и были исключены. Всего в исследовании приняло участие 29 человек (49,1% от исходного количества). Основные причины отказа от мониторинга: нет тонометра (30%), нет доверия к технологиям (23,3%), нет электронной почты (16,7%), нет свободного времени (13,3%), без причины (16,7%).

 При наблюдении в течение 1 месяца средний уровень систолического АД в исследовании составил 115±3,7  мм.рт.ст., средний уровень диастолического АД — 73±2,8 мм рт.ст., средний уровень ЧСС — 84±3,5 в минуту.   Из 29 беременных, находящихся на мониторинге, 17 беременных (58,6%), завершили программу мониторинга в установленные сроки. 12 женщин (41,8%) (средний возраст 33,1±3,1 года) завершили мониторинг досрочно.

 Выводы

 Выводы. Самостоятельный дистанционный мониторинг беременных высокого риска является возможной технологией для осуществления удаленного наблюдения.

Aim

Aim. To study the possibilities of self-remote monitoring of blood pressure and heart rate in high-risk pregnant women.

 Material and methods

 Material and methods. Women from 18 to 45 years old with hypertension (chronic and gestational), a history of preeclampsia, a high level of preeclampsia risk (above 1:100), body mass index (BMI) > 30 kg/m2 were included in the study to test selfmonitoring of blood pressure using the MedSenger platform. The patients used a home tonometer to measure blood pressure and heart rate daily in the morning and evening and entered data into the personal account of the MedSenger application for 1 month. The doctor monitored the parameters of pregnant women, received notifications in case of deviations and decided on further tactics.

 Results

 Results. We planned to include 59 patients in the study, but 25 women (42.4%) refused to participate. 5 Out of 34 pregnant women (average age 30.1±2.3 years) did not activate the program and were excluded. Finally, 29 women took part in the study (49.1% of the initial number). The main reasons for refusing monitoring: no tonometer (30%), no trust in technology (23.3%), no email adress (16.7%), no free time (13.3%), no reason (16.7%).

The average systolic blood pressure in the study was 115±3.7 mmHg, the average diastolic blood pressure was 73±2.8 mmHg, the average heart rate was 84±3.5 per minute. 17 (58.6%) out of the 29 pregnant women completed the monitoring program on time. 12 women (41.8%) (average age 33.1±3.1 years) completed monitoring ahead of schedule.

 Conclusions

 Conclusions. Self-remote monitoring of high-risk pregnant women is a feasible technology for remote monitoring.

беременностьвысокий рискартериальная гипертензиядистанционное наблюдениетелемедицинские технологииpregnancyhigh riskarterial hypertensionremote monitoringtelemedicine technologiesReferencesTrends in Maternal Mortality: 2000 to 2017: Estimates by WHO, UNICEF, UNFPA, World Bank Group and the United Nations Population Division. Geneva: World Health Organization. Available at: https://www.who.int/news-room/fact-sheets/detail/maternal-mortality. Accessed May 26, 2023.Trends in Maternal Mortality: 2000 to 2017: Estimates by WHO, UNICEF, UNFPA, World Bank Group and the United Nations Population Division. Geneva: World Health Organization. Available at: https://www.who.int/news-room/fact-sheets/detail/maternal-mortality. Accessed May 26, 2023.Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). What Are Some Factors That Make a Pregnancy High Risk? Available at: https://www.nichd.nih.gov/health/topics/high-risk/conditioninfo/factors#f1/. Accessed May 26, 2023.Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). What Are Some Factors That Make a Pregnancy High Risk? Available at: https://www.nichd.nih.gov/health/topics/high-risk/conditioninfo/factors#f1/. Accessed May 26, 2023.Say L, Chou D, Gemmill A, Tunçalp Ö, Moller AB, Daniels J, Gülmezoglu AM, Temmerman M, Alkema L. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health. 2014; 2(6): e323-33. doi: 10.1016/S2214-109X(14)70227-X.Say L, Chou D, Gemmill A, Tunçalp Ö, Moller AB, Daniels J, Gülmezoglu AM, Temmerman M, Alkema L. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health. 2014; 2(6): e323-33. doi: 10.1016/S2214-109X(14)70227-X.Ghulmiyyah L, Sibai B. Maternal mortality from preeclampsia/eclampsia. Semin Perinatol. 2012; 36(1): 56-9. doi: 10.1053/j.semperi.2011.09.011.Ghulmiyyah L, Sibai B. Maternal mortality from preeclampsia/eclampsia. Semin Perinatol. 2012; 36(1): 56-9. doi: 10.1053/j.semperi.2011.09.011.English FA, Kenny LC, McCarthy FP. Risk factors and effective management of preeclampsia. Integr Blood Press Control. 2015; 8: 7-12. doi: 10.2147/IBPC.S50641.English FA, Kenny LC, McCarthy FP. Risk factors and effective management of preeclampsia. Integr Blood Press Control. 2015; 8: 7-12. doi: 10.2147/IBPC.S50641.Shanmugalingam R, Wang X, Motum P, Fulcher I, Lee G, Kumar R, et al. Clinical influence of nonadherence with prophylactic aspirin in preventing preeclampsia in high-risk pregnancies: a multicenter, prospective, observational cohort study. Hypertension. 2020; 75(4): 1125-32. doi: 10.1161/HYPERTENSIONAHA.119.14107.Shanmugalingam R, Wang X, Motum P, Fulcher I, Lee G, Kumar R, et al. Clinical influence of nonadherence with prophylactic aspirin in preventing preeclampsia in high-risk pregnancies: a multicenter, prospective, observational cohort study. Hypertension. 2020; 75(4): 1125-32. doi: 10.1161/HYPERTENSIONAHA.119.14107.Powe CE, Levine RJ, Karumanchi SA. Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease. Circulation. 2011; 123(24): 2856-69. doi: 10.1161/CIRCULATIONAHA.109.853127.Powe CE, Levine RJ, Karumanchi SA. Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease. Circulation. 2011; 123(24): 2856-69. doi: 10.1161/CIRCULATIONAHA.109.853127.Tooher J, Chiu CL, Yeung K, Lupton SJ, Thornton C, Makris A, et al. High blood pressure during pregnancy is associated with future cardiovascular disease: an observational cohort study. BMJ Open. 2013; 3(7): e002964. doi: 10.1136/bmjopen-2013-002964.Tooher J, Chiu CL, Yeung K, Lupton SJ, Thornton C, Makris A, et al. High blood pressure during pregnancy is associated with future cardiovascular disease: an observational cohort study. BMJ Open. 2013; 3(7): e002964. doi: 10.1136/bmjopen-2013-002964.Kristensen JH, Basit S, Wohlfahrt J, Damholt MB, Boyd HA. Pre-eclampsia and risk of later kidney disease: nationwide cohort study. BMJ. 2019; 365: l1516. doi: 10.1136/bmj.l1516.Kristensen JH, Basit S, Wohlfahrt J, Damholt MB, Boyd HA. Pre-eclampsia and risk of later kidney disease: nationwide cohort study. BMJ. 2019; 365: l1516. doi: 10.1136/bmj.l1516.Сухих Г.Т., Оганов Р.Г., Ткачева О.Н. и др. Результаты Российского многоцентрового эпидемиологического исследования «Лечебно-диагностическая тактика ведения беременных с артериальной гипертонией в России «Диалог II» // Артериальная гипертензия. — 2010. — Т.16. — №1. — С.45-51.Sukhikh GT, Oganov RG, Tkacheva ON, et al. Rezul'taty Rossijskogo mnogocentrovogo epidemiologicheskogo issledovaniya «Lechebno-diagnosticheskaya taktika vedeniya beremennyh s arterial'noj gipertoniej v Rossii «Dialog II». Arterial'naya gipertenziya. 2010; 16(1): 45-51. (In Russ.)Yoder SR, Thornburg LL, Bisognano JD. Hypertension in pregnancy and women of childbearing age. Am J Med. 2009; 122: 890-895. doi: 10.1016/j.amjmed.2009.03.036.Yoder SR, Thornburg LL, Bisognano JD. Hypertension in pregnancy and women of childbearing age. Am J Med. 2009; 122: 890-895. doi: 10.1016/j.amjmed.2009.03.036.Mathews TJ, Hamilton BE. Delayed childbearing: more women are having their first child later in life. National Center for Health Statistics Data Brief. 2009; 21.Mathews TJ, Hamilton BE. Delayed childbearing: more women are having their first child later in life. National Center for Health Statistics Data Brief. 2009; 21.Bateman BT, Bansil P, Hernandez-Diaz S, Mhyre JM, Callaghan WM, Kuklina EV. Prevalence, trends, and outcomes of chronic hypertension: a nationwide sample of delivery admissions. Am J Obstet Gynecol. 2012; 206: 134.e1-8. doi: 10.1016/j.ajog.2011.10.878.Bateman BT, Bansil P, Hernandez-Diaz S, Mhyre JM, Callaghan WM, Kuklina EV. Prevalence, trends, and outcomes of chronic hypertension: a nationwide sample of delivery admissions. Am J Obstet Gynecol. 2012; 206: 134.e1-8. doi: 10.1016/j.ajog.2011.10.878.Bramham K, Parnell B, Nelson-Piercy C, Seed PT, Poston L, Chappell LC. Chronic hypertension and pregnancy outcomes: systematic review and meta-analysis. BMJ. 2014; 348: g2301. doi: 10.1136/bmj.g2301.Bramham K, Parnell B, Nelson-Piercy C, Seed PT, Poston L, Chappell LC. Chronic hypertension and pregnancy outcomes: systematic review and meta-analysis. BMJ. 2014; 348: g2301. doi: 10.1136/bmj.g2301.Rath W, Fischer T. The diagnosis and treatment of hypertensive disorders of pregnancy. Dtsch Arztebl Int. 2009; 106(45): 733-8. doi: 10.3238/artebl.2009.0733.Rath W, Fischer T. The diagnosis and treatment of hypertensive disorders of pregnancy. Dtsch Arztebl Int. 2009; 106(45): 733-8. doi: 10.3238/artebl.2009.0733.Borges do Nascimento IJ, Abdulazeem HM, Vasanthan LT, Martinez EZ, Zucoloto ML, et al. The global effect of digital health technologies on health workers' competencies and health workplace: an umbrella review of systematic reviews and lexical-based and sentence-based meta-analysis. Lancet Digit Health. 2023; 5(8): e534-e544. doi: 10.1016/S2589-7500(23)00092-4.Borges do Nascimento IJ, Abdulazeem HM, Vasanthan LT, Martinez EZ, Zucoloto ML, et al. The global effect of digital health technologies on health workers' competencies and health workplace: an umbrella review of systematic reviews and lexical-based and sentence-based meta-analysis. Lancet Digit Health. 2023; 5(8): e534-e544. doi: 10.1016/S2589-7500(23)00092-4.Lanssens D, Vonck S, Storms V, Thijs IM, Grieten L, Gyselaers W. The impact of a remote monitoring program on the prenatal follow-up of women with gestational hypertensive disorders. J Med Internet Res. 2018; 223: 72-8. doi: 10.1016/j.ejogrb.2018.02.015.Lanssens D, Vonck S, Storms V, Thijs IM, Grieten L, Gyselaers W. The impact of a remote monitoring program on the prenatal follow-up of women with gestational hypertensive disorders. J Med Internet Res. 2018; 223: 72-8. doi: 10.1016/j.ejogrb.2018.02.015.Lanssens D, Vandenberk T, Smeets C, De Cannière H, Vonck S, Claessens J, et al. Cost- analysis of prenatal remote monitoring of women with gestational hypertensive diseases. J Med Internet Res. 2018; 20(3): e102. doi: 10.2196/jmir.9552.Lanssens D, Vandenberk T, Smeets C, De Cannière H, Vonck S, Claessens J, et al. Cost- analysis of prenatal remote monitoring of women with gestational hypertensive diseases. J Med Internet Res. 2018; 20(3): e102. doi: 10.2196/jmir.9552.Lanssens D, Vonck S, Vandenberk T, Schraepen C, Storms V, Thijs IM, et al. A prenatal remote monitoring program in pregnancies complicated with gestational hypertensive disorders: what are the contributors to the cost savings? Telemed J E Health. 2019; 25(8): 686-92. doi: 10.1089/tmj.2018.0147.Lanssens D, Vonck S, Vandenberk T, Schraepen C, Storms V, Thijs IM, et al. A prenatal remote monitoring program in pregnancies complicated with gestational hypertensive disorders: what are the contributors to the cost savings? Telemed J E Health. 2019; 25(8): 686-92. doi: 10.1089/tmj.2018.0147.Imershein AW, Turner C, Wells JG, Pearman A. Covering the costs of care in neonatal intensive care units. Pediatrics. 1992; 89(1): 56-61.Imershein AW, Turner C, Wells JG, Pearman A. Covering the costs of care in neonatal intensive care units. Pediatrics. 1992; 89(1): 56-61.Pourat N, Martinez AE, Jones JM, Gregory KD, Korst L, Kominski GF. Costs of gestational hypertensive disorders in California: hypertension, preeclampsia, and Eclampsia. Los Angles: UCLA Center for Health Policy Research; 2013.Pourat N, Martinez AE, Jones JM, Gregory KD, Korst L, Kominski GF. Costs of gestational hypertensive disorders in California: hypertension, preeclampsia, and Eclampsia. Los Angles: UCLA Center for Health Policy Research; 2013.Cuevas MAR, Martínez IL, Domínguez EL, Velázquez YH, Isidro SD, et al. Telemonitoring System Oriented towards High-Risk Pregnant Women. Healthcare. 2022; 10(12): 2484. doi: 10.3390/healthcare10122484.Cuevas MAR, Martínez IL, Domínguez EL, Velázquez YH, Isidro SD, et al. Telemonitoring System Oriented towards High-Risk Pregnant Women. Healthcare. 2022; 10(12): 2484. doi: 10.3390/healthcare10122484.Aquino M, Munce S, Griffith J, Pakosh M, Munnery M, et al. Exploring the Use of Telemonitoring for Patients at High Risk for Hypertensive Disorders of Pregnancy in the Antepartum and Postpartum Periods: Scoping Review. JMIR Mhealth Uhealth. 2020; 8(4): e15095. doi: 10.2196/15095.Aquino M, Munce S, Griffith J, Pakosh M, Munnery M, et al. Exploring the Use of Telemonitoring for Patients at High Risk for Hypertensive Disorders of Pregnancy in the Antepartum and Postpartum Periods: Scoping Review. JMIR Mhealth Uhealth. 2020; 8(4): e15095. doi: 10.2196/15095.Perry H, Sheehan E, Thilaganathan B, Khalil A. Home blood-pressure monitoring in a hypertensive pregnant population. Ultrasound Obstet Gynecol. 2018; 51(4): 524-530. doi: 10.1002/uog.19023.Perry H, Sheehan E, Thilaganathan B, Khalil A. Home blood-pressure monitoring in a hypertensive pregnant population. Ultrasound Obstet Gynecol. 2018; 51(4): 524-530. doi: 10.1002/uog.19023.Анкудинов Н.О., Ситников А.Ф., Ситников Ф.А. и др. Дистанционный мониторинг состояния здоровья беременных в группе риска по преэклампсии // Врач. — 2022. — Т.33. — №1. — С.49-52.Ankudinov NO, Sitnikov AF, Sitnikov FA. Distancionnyj monitoring sostoyaniya zdorov'ya beremennyh v gruppe riska po preeklampsii. Vrach. 2022; 33(1): 49-52. (In Russ.)] doi:10.29296/25877305-2022-01-07.Анкудинов Н.О., Ситников А.Ф., Ситников Ф.А. Как оптимизировать работу службы родов споможения с помощью «бережливых» информационных технологий // Российский журнал телемедицины и электронного здравоохранения. — 2021. — №7. — №4. — С.58-62. doi: 10.29188/2712-9217-2021-7-4-58-62Ankudinov NO, Sitnikov AF, Sitnikov FA. How to optimize the work in obstetrics with the help of «lean» information technologies. Russian Journal of Telemedicine and E-Health. 2021; 7(4): 58-62. (In Russ.)] doi: 10.29188/2712-9217-2021-7-4-58-62.Концевая А. В., Шальнова С. А., Драпкина О. М. Исследование ЭССЕ-РФ: эпидемиология и укрепление общественного здоровья // Кардиоваскулярная терапия и профилактика. — 2021. — Т.20. — №5. — С.225-232. doi:10.15829/1728-8800-2021-2987Kontsevaya AV, Shalnova SA, Drapkina OM. ESSERF study: epidemiology and public health promotion. Cardiovascular Therapy and Prevention. 2021; 20(5): 225-232. (In Russ.)] doi:10.15829/1728-8800-2021-2987.Zhou B, Carrillo-Larco RM, Danaei G, et al. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021; 398(10304): 957-80. doi: 10.1016/S0140-6736(21)01330-1.Zhou B, Carrillo-Larco RM, Danaei G, et al. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021; 398(10304): 957-80. doi: 10.1016/S0140-6736(21)01330-1.Burnier M, Egan BM. Adherence in Hypertension. Circ Res. 2019; 124(7): 1124-40. doi: 10.1161/CIRCRESAHA.118.313220.Burnier M, Egan BM. Adherence in Hypertension. Circ Res. 2019; 124(7): 1124-40. doi: 10.1161/CIRCRESAHA.118.313220.Abegaz TM, Shehab A, Gebreyohannes EA, et al. Nonadherence to antihypertensive drugs: A systematic review and meta-analysis. Medicine (Baltimore). 2017; 96(4): e5641. doi: 10.1097/MD.0000000000005641.Abegaz TM, Shehab A, Gebreyohannes EA, et al. Nonadherence to antihypertensive drugs: A systematic review and meta-analysis. Medicine (Baltimore). 2017; 96(4): e5641. doi: 10.1097/MD.0000000000005641.Шальнова С.А., Конради А.О., Баланова Ю.А. и др. Какие факторы влияют на контроль артериальной гипертонии в России // Кардиоваскулярная терапия и профилактика. — 2018. — Т.17. — №4. — С.53-60. doi: 10.15829/1728-8800-2018-4-53-60Shalnova SA, Konradi AО, Balanova YuA, et al. What factors do influence arterial hypertension control in Russia. Cardiovascular Therapy and Prevention. 2018; 17(4): 53-60. (In Russ.) doi: 10.15829/1728-8800-2018-4-53-60.Lee EKP, Poon P, Yip BHK, et al. Global Burden, Regional Differences, Trends, and Health Consequences of Medication Nonadherence for Hypertension During 2010 to 2020: A MetaAnalysis Involving 27 Million Patients. J Am Heart Assoc. 2022; 11(17): e026582. doi: 10.1161/JAHA.122.026582.Lee EKP, Poon P, Yip BHK, et al. Global Burden, Regional Differences, Trends, and Health Consequences of Medication Nonadherence for Hypertension During 2010 to 2020: A MetaAnalysis Involving 27 Million Patients. J Am Heart Assoc. 2022; 11(17): e026582. doi: 10.1161/JAHA.122.026582.Helou A, Stewart K, George J. Adherence to anti-hypertensive medication in pregnancy. Pregnancy Hypertens. 2021; 25: 230-234. doi: 10.1016/j.preghy.2021.06.002.Helou A, Stewart K, George J. Adherence to anti-hypertensive medication in pregnancy. Pregnancy Hypertens. 2021; 25: 230-234. doi: 10.1016/j.preghy.2021.06.002.Bowen L, Pealing L, Tucker K, McManus RJ, Chappell LC. Adherence with blood pressure self monitoring in women with pregnancy hypertension, and comparisons to clinic readings: A secondary analysis of OPTIMUM-BP. Pregnancy Hypertens. 2021; 25: 68-74. doi: 10.1016/j.preghy.2021.05.016.Bowen L, Pealing L, Tucker K, McManus RJ, Chappell LC. Adherence with blood pressure self monitoring in women with pregnancy hypertension, and comparisons to clinic readings: A secondary analysis of OPTIMUM-BP. Pregnancy Hypertens. 2021; 25: 68-74. doi: 10.1016/j.preghy.2021.05.016.Митрофанова И.С., Столбова М.В., Шарапов С.В. Морина А.А. Приверженность к лечению беременных женщин с артериальной гипертензией // Национальная ассоциация ученых. — 2015. — Т.4. — №9. — С.9-81.Mitrofanova IS, Stolbova MV, Sharapov SV, Morina AA. The compliance of pregnant women with arterial hypertension. Nacional'naya associaciya uchenyh. 2015; 4(9): 9-81. (In Russ.)Жусупова Ж.К., Зейналова Д.Э., Крюкова А.Ю. Ключевая детерминанта приверженности к лечению артериальной гипертензии у беременных женщин как профилактика акушерских осложнений // Вестник совета молодых ученых и специалистов Челябинской области. — 2020. — Т.1. — №28. — С.17-21.Zhusupova ZhK, Zejnalova DE, Kryukova AYU. Main determinants of addition to treatment of arterial hypertension in pregnant women as prevention of ancient complications. Vestnik soveta molodyh uchyonyh i specialistov Chelyabinskoj oblasti. 2020; 1(28): 17-21. (In Russ.)Шадеркин И.А. Барьеры телемедицины и пути их преодоления // Российский журнал теле медицины и электронного здравоохранения. — 2022. — Т.8. — №2. — С.59-76. doi: 10.29188/2712-9217-2022-8-2-59-76Shaderkin IA. Telemedicine barriers and ways to overcome them. Russian Journal of Telemedicine and E-Health. 2022; 8(2): 59-76. (In Russ.)] doi: 10.29188/2712-9217-2022-8-2-59-76Vandenberk T, Lanssens D, Storms V, Thijs IM, Bamelis L, Grieten L, Gyselaers W, Tang E, Luyten P. Relationship between adherence to remote monitoring and patient characteristics: observational study in women with pregnancy-induced hypertension. JMIR MhealthUhealth. 2019; 7(8): e12574. doi: 10.2196/12574.Vandenberk T, Lanssens D, Storms V, Thijs IM, Bamelis L, Grieten L, Gyselaers W, Tang E, Luyten P. Relationship between adherence to remote monitoring and patient characteristics: observational study in women with pregnancy-induced hypertension. JMIR MhealthUhealth. 2019; 7(8): e12574. doi: 10.2196/12574.van den Heuvel JFM, Teunis CJ, Franx A, Crombag NMTH, Bekker MN. Home-based telemonitoring versus hospital admission in high risk pregnancies: a qualitative study on women's experiences. BMC Pregnancy Childbirth. 2020; 20(1): 77. doi: 10.1186/s12884-020-2779-4.van den Heuvel JFM, Teunis CJ, Franx A, Crombag NMTH, Bekker MN. Home-based telemonitoring versus hospital admission in high risk pregnancies: a qualitative study on women's experiences. BMC Pregnancy Childbirth. 2020; 20(1): 77. doi: 10.1186/s12884-020-2779-4.Kerner RYY, Belkin A, Ben-Haroush A, Zeevi B, Hod M. Maternal self-administered fetal heart rate monitoring and transmission from home in high-risk pregnancies. Int J Gynecol Obstet. 2004; 84(1): 33-9. doi: 10.1016/s0020-7292(03)00331-x.Kerner RYY, Belkin A, Ben-Haroush A, Zeevi B, Hod M. Maternal self-administered fetal heart rate monitoring and transmission from home in high-risk pregnancies. Int J Gynecol Obstet. 2004; 84(1): 33-9. doi: 10.1016/s0020-7292(03)00331-x.Бабаева А.Д. Взаимообусловленность показателей качества жизни и приверженности к лечению и профилактике артериальной гипертонии среди женщин репродуктивного возраста // Актуальні проблеми сучасної медицини: Вісник української медичної стоматологічної академії. — 2016. — №3(55). — С.33-37.Babaeva AD. Vzaimoobuslovlennost' pokazatelej kachestva zhizni i priverzhennosti k lecheniyu i profilaktike arterial'noj gipertonii sredi zhenshchin reproduktivnogo vozrasta. Aktual'nі problemi suchasnoї medicini: Vіsnik ukraїns'koї medichnoї stomatologіchnoї akademії. 2016; 3(55): 33-37. (In Russ.)Дорофеева Е.Г., Виноградов В.Е., Бердинский В.А. Применение телемедицинских технологий в наблюдении и поддержке пациентов нефрологического профиля // Digital Diagnostics. — 2022. — Т.3. — №S1. — С.25-26. doi: 10.17816/DD105745Dorofeeva EG, Vinogradov VE, Berdinskiy VA. The use of telemedicine technologies in monitoring and supporting of nephrological patients. Digital Diagnostics. 2022; 3(S1): 25-26. (In Russ.)] doi: 10.17816/DD105745.

The authors declare that there are no conflicts of interest present.